Hospira gets FDA warning letter about Australia plant

SHARE Hospira gets FDA warning letter about Australia plant

Hospira Inc. has received a warning letter from the U.S. Food and Drug Administration related to an inspection of the drugmaker’s operations at an Australian plant.

The FDA letter, which Hospira said it received Monday, said the company had not adequately fixed production problems found during an inspection of the Mulgrave, Australia, plant between Feb. 24 and March 1. The plant makes specialty injectable drugs.

“The company is evaluating what corrective actions may be required, and associated costs may be incurred, to address the matters raised in the warning letter,” Hospira said in a statement. “The company takes this matter seriously, and intends to respond fully and in a timely manner to the FDA’s warning letter.”

Lake Forest-based Hospira said it doesn’t expect the warning letter will affect its 2014 financial guidance.

The Latest
Another federal judge in Chicago who also has dismissed gun cases based on the same Supreme Court ruling says the high court’s decision in what’s known as the Bruen case will “inevitably lead to more gun violence, more dead citizens and more devastated communities.”
The way inflation is measured masks certain costs that add to the prices that consumers pay every day. Not surprisingly, higher costs mean lower consumer confidence, no matter what Americans are told about an improving economy.
With Easter around the corner, chocolate makers and food businesses are feeling the impact of soaring global cocoa prices and it’s also hitting consumers.
Despite getting into foul trouble, which limited him to just six minutes in the second half, Shannon finished with 29 points, five rebounds and two assists.